Amid this epidemic, a transformative class of medications GLP-1 receptor agonists (GLP- 1RAs) has revolutionized weight loss and chronic disease management
20% of body weight) are more likely to notice hair loss with GLP-1 RA usage.[ref] Studies note that this also occurs with other forms of weight loss, like bariatric surgery, and could be tied to reduced intake of nutrients such as protein, iron, biotin, or zinc
Different GLP-1 receptor agonists have varying pharmacokinetic profiles and receptor binding characteristics
Liu, H., Zhan, Y
The question is who it will serve, and whether the ultimate prize is treatment, profit, or ownership of hunger itself
News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years